171 related articles for article (PubMed ID: 17367358)
1. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
Hreybe H; Saba S
Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
[TBL] [Abstract][Full Text] [Related]
2. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
3. Renal insufficiency predicts the time to first appropriate defibrillator shock.
Hreybe H; Ezzeddine R; Bedi M; Barrington W; Bazaz R; Ganz LI; Jain S; Ngwu O; London B; Saba S
Am Heart J; 2006 Apr; 151(4):852-6. PubMed ID: 16569548
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
5. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.
Verma A; Kilicaslan F; Martin DO; Minor S; Starling R; Marrouche NF; Almahammed S; Wazni OM; Duggal S; Zuzek R; Yamaji H; Cummings J; Chung MK; Tchou PJ; Natale A
Heart; 2006 Feb; 92(2):190-5. PubMed ID: 15923278
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
8. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
[TBL] [Abstract][Full Text] [Related]
10. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.
Hreybe H; Razak E; Saba S
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1091-5. PubMed ID: 17725751
[TBL] [Abstract][Full Text] [Related]
11. Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.
Borleffs CJ; Scherptong RW; Man SC; van Welsenes GH; Bax JJ; van Erven L; Swenne CA; Schalij MJ
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):548-54. PubMed ID: 19843923
[TBL] [Abstract][Full Text] [Related]
12. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
Alsheikh-Ali AA; Homer M; Maddukuri PV; Kalsmith B; Estes NA; Link MS
J Cardiovasc Electrophysiol; 2008 Aug; 19(8):784-9. PubMed ID: 18284493
[TBL] [Abstract][Full Text] [Related]
13. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
14. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients.
Chen-Scarabelli C; Scarabelli TM
Pacing Clin Electrophysiol; 2007 Mar; 30(3):371-6. PubMed ID: 17367356
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
[TBL] [Abstract][Full Text] [Related]
16. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
Bruch C; Bruch C; Sindermann J; Breithardt G; Gradaus R
Europace; 2007 Aug; 9(8):681-6. PubMed ID: 17507354
[TBL] [Abstract][Full Text] [Related]
18. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
[TBL] [Abstract][Full Text] [Related]
19. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
